Facebook
Twitter
LinkedIn
ForwardREPRIEVE Trial Results: AlbanyMed
April 17, 2024
Target Audience
All pharmacists
Learning Objectives
Describe cardiovascular disease among people with HIV and the unique features of cardiovascular disease in the context of HIV.
Explain the results of the REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) trial in people with HIV.
Determine primary prevention measures for cardiovascular disease shown to be effective among people with HIV.
VIA ZOOM
United States
Zoom link will be sent to you directly through email
- Kathleen Fitch- Bio
- Kathleen Fitch is a Clinical Research Nurse Practitioner in the Massachusetts General Hospital Metabolism Unit. She earned her Master’s of Science in Nursing (Family Nurse Practitioner) at the Massachusetts General Hospital Institute of Health Professions.
- Katie has organized, directed and completed several NIH R01-funded clinical research studies focusing on the assessment and treatment of metabolic complications in HIV. Her experience includes authorship of several peer reviewed manuscripts and she is an Ad Hoc reviewer for several journals. In addition to her research experience, Katie has served as a National Health Service Corps Scholar and she has worked in primary care as a nurse practitioner at the Boston Health Care for the Homeless Program. She is also a volunteer community educator at several AIDS service organizations throughout Massachusetts.
- Katie is the Project Manager for the REPRIEVE Clinical Coordinating Center.
ACPE UAN #
0042-9999-24-024-L02-P
Available Credit
- 1.00 ACPE
The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.